nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—SCN8A—epilepsy syndrome	0.0882	0.23	CbGaD
Phenazopyridine—SCN9A—epilepsy syndrome	0.0714	0.186	CbGaD
Phenazopyridine—SCN3A—epilepsy syndrome	0.0682	0.178	CbGaD
Phenazopyridine—SCN4A—epilepsy syndrome	0.0656	0.171	CbGaD
Phenazopyridine—SCN1A—epilepsy syndrome	0.0479	0.125	CbGaD
Phenazopyridine—SCN2A—epilepsy syndrome	0.0423	0.11	CbGaD
Phenazopyridine—SCN7A—Rufinamide—epilepsy syndrome	0.0269	0.0589	CbGbCtD
Phenazopyridine—SCN11A—Rufinamide—epilepsy syndrome	0.0214	0.0468	CbGbCtD
Phenazopyridine—SCN8A—Lamotrigine—epilepsy syndrome	0.0202	0.0443	CbGbCtD
Phenazopyridine—SCN8A—Rufinamide—epilepsy syndrome	0.0179	0.0391	CbGbCtD
Phenazopyridine—SCN8A—Phenytoin—epilepsy syndrome	0.0156	0.0342	CbGbCtD
Phenazopyridine—SCN11A—Zonisamide—epilepsy syndrome	0.0154	0.0337	CbGbCtD
Phenazopyridine—SCN9A—Lamotrigine—epilepsy syndrome	0.0132	0.029	CbGbCtD
Phenazopyridine—SCN9A—Lacosamide—epilepsy syndrome	0.0132	0.029	CbGbCtD
Phenazopyridine—SCN3A—Lacosamide—epilepsy syndrome	0.0121	0.0265	CbGbCtD
Phenazopyridine—SCN3A—Lamotrigine—epilepsy syndrome	0.0121	0.0265	CbGbCtD
Phenazopyridine—SCN9A—Rufinamide—epilepsy syndrome	0.0117	0.0256	CbGbCtD
Phenazopyridine—SCN9A—Carbamazepine—epilepsy syndrome	0.0114	0.0249	CbGbCtD
Phenazopyridine—SCN4A—Lamotrigine—epilepsy syndrome	0.0112	0.0245	CbGbCtD
Phenazopyridine—SCN2A—Lamotrigine—epilepsy syndrome	0.0112	0.0245	CbGbCtD
Phenazopyridine—SCN3A—Rufinamide—epilepsy syndrome	0.0107	0.0234	CbGbCtD
Phenazopyridine—SCN10A—Lacosamide—epilepsy syndrome	0.0104	0.0227	CbGbCtD
Phenazopyridine—SCN10A—Lamotrigine—epilepsy syndrome	0.0104	0.0227	CbGbCtD
Phenazopyridine—SCN1A—Lamotrigine—epilepsy syndrome	0.0104	0.0227	CbGbCtD
Phenazopyridine—SCN9A—Phenytoin—epilepsy syndrome	0.0102	0.0224	CbGbCtD
Phenazopyridine—SCN4A—Rufinamide—epilepsy syndrome	0.00987	0.0216	CbGbCtD
Phenazopyridine—SCN2A—Rufinamide—epilepsy syndrome	0.00987	0.0216	CbGbCtD
Phenazopyridine—SCN5A—Oxcarbazepine—epilepsy syndrome	0.00974	0.0213	CbGbCtD
Phenazopyridine—SCN4A—Carbamazepine—epilepsy syndrome	0.00962	0.0211	CbGbCtD
Phenazopyridine—SCN3A—Phenytoin—epilepsy syndrome	0.00935	0.0205	CbGbCtD
Phenazopyridine—SCN10A—Rufinamide—epilepsy syndrome	0.00918	0.0201	CbGbCtD
Phenazopyridine—SCN1A—Rufinamide—epilepsy syndrome	0.00918	0.0201	CbGbCtD
Phenazopyridine—SCN2A—Phenytoin—epilepsy syndrome	0.00863	0.0189	CbGbCtD
Phenazopyridine—SCN4A—Phenytoin—epilepsy syndrome	0.00863	0.0189	CbGbCtD
Phenazopyridine—SCN5A—Fosphenytoin—epilepsy syndrome	0.00851	0.0186	CbGbCtD
Phenazopyridine—SCN9A—Zonisamide—epilepsy syndrome	0.00843	0.0184	CbGbCtD
Phenazopyridine—SCN4A—Propofol—epilepsy syndrome	0.00805	0.0176	CbGbCtD
Phenazopyridine—SCN2A—Propofol—epilepsy syndrome	0.00805	0.0176	CbGbCtD
Phenazopyridine—SCN1A—Phenytoin—epilepsy syndrome	0.00802	0.0176	CbGbCtD
Phenazopyridine—SCN3A—Zonisamide—epilepsy syndrome	0.00771	0.0169	CbGbCtD
Phenazopyridine—SCN2A—Zonisamide—epilepsy syndrome	0.00711	0.0156	CbGbCtD
Phenazopyridine—SCN4A—Zonisamide—epilepsy syndrome	0.00711	0.0156	CbGbCtD
Phenazopyridine—SCN5A—Lamotrigine—epilepsy syndrome	0.0071	0.0155	CbGbCtD
Phenazopyridine—SCN1A—Zonisamide—epilepsy syndrome	0.00662	0.0145	CbGbCtD
Phenazopyridine—SCN5A—Rufinamide—epilepsy syndrome	0.00627	0.0137	CbGbCtD
Phenazopyridine—SCN5A—Carbamazepine—epilepsy syndrome	0.00611	0.0134	CbGbCtD
Phenazopyridine—SCN5A—Phenytoin—epilepsy syndrome	0.00548	0.012	CbGbCtD
Phenazopyridine—SCN1A—Topiramate—epilepsy syndrome	0.00482	0.0106	CbGbCtD
Phenazopyridine—SCN5A—Zonisamide—epilepsy syndrome	0.00452	0.0099	CbGbCtD
Phenazopyridine—SCN3A—spinal nerve—epilepsy syndrome	0.00443	0.135	CbGeAlD
Phenazopyridine—SCN8A—cerebellar cortex—epilepsy syndrome	0.00382	0.116	CbGeAlD
Phenazopyridine—SCN5A—Topiramate—epilepsy syndrome	0.0033	0.00721	CbGbCtD
Phenazopyridine—SCN11A—ganglion—epilepsy syndrome	0.00182	0.0556	CbGeAlD
Phenazopyridine—SCN8A—hindbrain—epilepsy syndrome	0.00105	0.0319	CbGeAlD
Phenazopyridine—SCN10A—ganglion—epilepsy syndrome	0.000925	0.0282	CbGeAlD
Phenazopyridine—SCN1A—hindbrain—epilepsy syndrome	0.000792	0.0241	CbGeAlD
Phenazopyridine—SCN2A—hindbrain—epilepsy syndrome	0.000727	0.0222	CbGeAlD
Phenazopyridine—SCN8A—brainstem—epilepsy syndrome	0.000601	0.0183	CbGeAlD
Phenazopyridine—SCN8A—forebrain—epilepsy syndrome	0.00058	0.0177	CbGeAlD
Phenazopyridine—SCN8A—telencephalon—epilepsy syndrome	0.000533	0.0162	CbGeAlD
Phenazopyridine—SCN11A—spinal cord—epilepsy syndrome	0.000493	0.015	CbGeAlD
Phenazopyridine—SCN1A—brainstem—epilepsy syndrome	0.000454	0.0138	CbGeAlD
Phenazopyridine—SCN1A—forebrain—epilepsy syndrome	0.000438	0.0134	CbGeAlD
Phenazopyridine—SCN11A—head—epilepsy syndrome	0.000438	0.0134	CbGeAlD
Phenazopyridine—SCN2A—brainstem—epilepsy syndrome	0.000417	0.0127	CbGeAlD
Phenazopyridine—SCN11A—nervous system—epilepsy syndrome	0.000415	0.0127	CbGeAlD
Phenazopyridine—SCN1A—telencephalon—epilepsy syndrome	0.000403	0.0123	CbGeAlD
Phenazopyridine—SCN2A—forebrain—epilepsy syndrome	0.000402	0.0123	CbGeAlD
Phenazopyridine—SCN11A—central nervous system—epilepsy syndrome	0.0004	0.0122	CbGeAlD
Phenazopyridine—SCN10A—forebrain—epilepsy syndrome	0.000388	0.0118	CbGeAlD
Phenazopyridine—SCN8A—spinal cord—epilepsy syndrome	0.000374	0.0114	CbGeAlD
Phenazopyridine—SCN7A—head—epilepsy syndrome	0.000373	0.0114	CbGeAlD
Phenazopyridine—SCN2A—telencephalon—epilepsy syndrome	0.00037	0.0113	CbGeAlD
Phenazopyridine—SCN10A—telencephalon—epilepsy syndrome	0.000357	0.0109	CbGeAlD
Phenazopyridine—SCN3A—forebrain—epilepsy syndrome	0.000354	0.0108	CbGeAlD
Phenazopyridine—SCN9A—midbrain—epilepsy syndrome	0.000337	0.0103	CbGeAlD
Phenazopyridine—Visual disturbance—Oxcarbazepine—epilepsy syndrome	0.000333	0.00685	CcSEcCtD
Phenazopyridine—SCN8A—head—epilepsy syndrome	0.000332	0.0101	CbGeAlD
Phenazopyridine—Nephrolithiasis—Gabapentin—epilepsy syndrome	0.00033	0.0068	CcSEcCtD
Phenazopyridine—SCN9A—spinal cord—epilepsy syndrome	0.000328	0.01	CbGeAlD
Phenazopyridine—SCN3A—telencephalon—epilepsy syndrome	0.000325	0.00991	CbGeAlD
Phenazopyridine—Haemolytic anaemia—Lamotrigine—epilepsy syndrome	0.000324	0.00667	CcSEcCtD
Phenazopyridine—SCN11A—brain—epilepsy syndrome	0.000317	0.00967	CbGeAlD
Phenazopyridine—SCN1A—medulla oblongata—epilepsy syndrome	0.000317	0.00965	CbGeAlD
Phenazopyridine—SCN8A—nervous system—epilepsy syndrome	0.000315	0.00959	CbGeAlD
Phenazopyridine—Visual impairment—Clobazam—epilepsy syndrome	0.000315	0.00648	CcSEcCtD
Phenazopyridine—SCN8A—central nervous system—epilepsy syndrome	0.000303	0.00924	CbGeAlD
Phenazopyridine—SCN8A—cerebellum—epilepsy syndrome	0.000296	0.00903	CbGeAlD
Phenazopyridine—SCN2A—medulla oblongata—epilepsy syndrome	0.000291	0.00886	CbGeAlD
Phenazopyridine—SCN1A—midbrain—epilepsy syndrome	0.000289	0.00882	CbGeAlD
Phenazopyridine—Gastrointestinal disorder—Primidone—epilepsy syndrome	0.000287	0.00592	CcSEcCtD
Phenazopyridine—SCN1A—spinal cord—epilepsy syndrome	0.000282	0.00861	CbGeAlD
Phenazopyridine—Nephrolithiasis—Topiramate—epilepsy syndrome	0.000278	0.00572	CcSEcCtD
Phenazopyridine—SCN7A—brain—epilepsy syndrome	0.00027	0.00823	CbGeAlD
Phenazopyridine—SCN2A—midbrain—epilepsy syndrome	0.000266	0.0081	CbGeAlD
Phenazopyridine—Jaundice—Diazepam—epilepsy syndrome	0.000263	0.00541	CcSEcCtD
Phenazopyridine—Hepatitis—Levetiracetam—epilepsy syndrome	0.000261	0.00538	CcSEcCtD
Phenazopyridine—Visual impairment—Propofol—epilepsy syndrome	0.000261	0.00536	CcSEcCtD
Phenazopyridine—SCN4A—head—epilepsy syndrome	0.00026	0.00793	CbGeAlD
Phenazopyridine—SCN2A—spinal cord—epilepsy syndrome	0.000259	0.0079	CbGeAlD
Phenazopyridine—SCN3A—medulla oblongata—epilepsy syndrome	0.000255	0.00779	CbGeAlD
Phenazopyridine—Visual impairment—Midazolam—epilepsy syndrome	0.000255	0.00525	CcSEcCtD
Phenazopyridine—Hypersensitivity—Amobarbital—epilepsy syndrome	0.000255	0.00524	CcSEcCtD
Phenazopyridine—Jaundice—Felbamate—epilepsy syndrome	0.000254	0.00523	CcSEcCtD
Phenazopyridine—SCN1A—head—epilepsy syndrome	0.000251	0.00765	CbGeAlD
Phenazopyridine—SCN10A—spinal cord—epilepsy syndrome	0.00025	0.00762	CbGeAlD
Phenazopyridine—SCN4A—nervous system—epilepsy syndrome	0.000247	0.00752	CbGeAlD
Phenazopyridine—SCN8A—brain—epilepsy syndrome	0.000241	0.00733	CbGeAlD
Phenazopyridine—SCN1A—nervous system—epilepsy syndrome	0.000238	0.00725	CbGeAlD
Phenazopyridine—SCN4A—central nervous system—epilepsy syndrome	0.000238	0.00724	CbGeAlD
Phenazopyridine—Visual impairment—Vigabatrin—epilepsy syndrome	0.000237	0.00487	CcSEcCtD
Phenazopyridine—Hepatitis—Felbamate—epilepsy syndrome	0.000234	0.00482	CcSEcCtD
Phenazopyridine—SCN3A—midbrain—epilepsy syndrome	0.000234	0.00712	CbGeAlD
Phenazopyridine—Visual impairment—Diazepam—epilepsy syndrome	0.000233	0.0048	CcSEcCtD
Phenazopyridine—SCN2A—head—epilepsy syndrome	0.00023	0.00702	CbGeAlD
Phenazopyridine—SCN1A—central nervous system—epilepsy syndrome	0.000229	0.00698	CbGeAlD
Phenazopyridine—SCN3A—spinal cord—epilepsy syndrome	0.000228	0.00694	CbGeAlD
Phenazopyridine—Jaundice—Carbamazepine—epilepsy syndrome	0.000227	0.00468	CcSEcCtD
Phenazopyridine—Visual impairment—Felbamate—epilepsy syndrome	0.000226	0.00464	CcSEcCtD
Phenazopyridine—Dyspepsia—Rufinamide—epilepsy syndrome	0.000224	0.00461	CcSEcCtD
Phenazopyridine—SCN1A—cerebellum—epilepsy syndrome	0.000224	0.00682	CbGeAlD
Phenazopyridine—SCN10A—head—epilepsy syndrome	0.000222	0.00677	CbGeAlD
Phenazopyridine—Visual disturbance—Pregabalin—epilepsy syndrome	0.000222	0.00456	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Rufinamide—epilepsy syndrome	0.00022	0.00452	CcSEcCtD
Phenazopyridine—Vomiting—Amobarbital—epilepsy syndrome	0.00022	0.00452	CcSEcCtD
Phenazopyridine—SCN2A—nervous system—epilepsy syndrome	0.000218	0.00666	CbGeAlD
Phenazopyridine—Hepatitis—Oxcarbazepine—epilepsy syndrome	0.000218	0.00449	CcSEcCtD
Phenazopyridine—Rash—Amobarbital—epilepsy syndrome	0.000218	0.00448	CcSEcCtD
Phenazopyridine—Dermatitis—Amobarbital—epilepsy syndrome	0.000218	0.00448	CcSEcCtD
Phenazopyridine—Headache—Amobarbital—epilepsy syndrome	0.000217	0.00446	CcSEcCtD
Phenazopyridine—Visual impairment—Clonazepam—epilepsy syndrome	0.000213	0.00438	CcSEcCtD
Phenazopyridine—Vomiting—Primidone—epilepsy syndrome	0.000212	0.00436	CcSEcCtD
Phenazopyridine—SCN9A—brain—epilepsy syndrome	0.000211	0.00644	CbGeAlD
Phenazopyridine—SCN10A—nervous system—epilepsy syndrome	0.000211	0.00642	CbGeAlD
Phenazopyridine—Dyspepsia—Lacosamide—epilepsy syndrome	0.00021	0.00433	CcSEcCtD
Phenazopyridine—Visual impairment—Oxcarbazepine—epilepsy syndrome	0.00021	0.00433	CcSEcCtD
Phenazopyridine—SCN2A—central nervous system—epilepsy syndrome	0.00021	0.00641	CbGeAlD
Phenazopyridine—Rash—Primidone—epilepsy syndrome	0.00021	0.00432	CcSEcCtD
Phenazopyridine—Dermatitis—Primidone—epilepsy syndrome	0.00021	0.00432	CcSEcCtD
Phenazopyridine—Hepatitis—Carbamazepine—epilepsy syndrome	0.000209	0.00431	CcSEcCtD
Phenazopyridine—Headache—Primidone—epilepsy syndrome	0.000209	0.00429	CcSEcCtD
Phenazopyridine—Pruritus—Trimethadione—epilepsy syndrome	0.000207	0.00426	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Lacosamide—epilepsy syndrome	0.000206	0.00425	CcSEcCtD
Phenazopyridine—SCN2A—cerebellum—epilepsy syndrome	0.000206	0.00626	CbGeAlD
Phenazopyridine—Nausea—Amobarbital—epilepsy syndrome	0.000205	0.00422	CcSEcCtD
Phenazopyridine—SCN10A—central nervous system—epilepsy syndrome	0.000203	0.00618	CbGeAlD
Phenazopyridine—SCN3A—head—epilepsy syndrome	0.000202	0.00617	CbGeAlD
Phenazopyridine—Hepatitis—Lamotrigine—epilepsy syndrome	0.000202	0.00417	CcSEcCtD
Phenazopyridine—SCN5A—head—epilepsy syndrome	0.000202	0.00615	CbGeAlD
Phenazopyridine—Gastrointestinal disorder—Clobazam—epilepsy syndrome	0.0002	0.00412	CcSEcCtD
Phenazopyridine—Nausea—Primidone—epilepsy syndrome	0.000198	0.00407	CcSEcCtD
Phenazopyridine—SCN3A—nervous system—epilepsy syndrome	0.000192	0.00585	CbGeAlD
Phenazopyridine—SCN5A—nervous system—epilepsy syndrome	0.000191	0.00583	CbGeAlD
Phenazopyridine—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000191	0.00393	CcSEcCtD
Phenazopyridine—SCN4A—brain—epilepsy syndrome	0.000189	0.00575	CbGeAlD
Phenazopyridine—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000188	0.00386	CcSEcCtD
Phenazopyridine—Vomiting—Trimethadione—epilepsy syndrome	0.000186	0.00383	CcSEcCtD
Phenazopyridine—SCN3A—central nervous system—epilepsy syndrome	0.000185	0.00563	CbGeAlD
Phenazopyridine—Rash—Trimethadione—epilepsy syndrome	0.000185	0.0038	CcSEcCtD
Phenazopyridine—Dermatitis—Trimethadione—epilepsy syndrome	0.000185	0.0038	CcSEcCtD
Phenazopyridine—SCN5A—central nervous system—epilepsy syndrome	0.000184	0.00562	CbGeAlD
Phenazopyridine—Headache—Trimethadione—epilepsy syndrome	0.000184	0.00378	CcSEcCtD
Phenazopyridine—Dyspepsia—Acetazolamide—epilepsy syndrome	0.000182	0.00375	CcSEcCtD
Phenazopyridine—SCN1A—brain—epilepsy syndrome	0.000182	0.00554	CbGeAlD
Phenazopyridine—SCN3A—cerebellum—epilepsy syndrome	0.000181	0.0055	CbGeAlD
Phenazopyridine—Pruritus—Rufinamide—epilepsy syndrome	0.00018	0.00371	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.000179	0.00367	CcSEcCtD
Phenazopyridine—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000176	0.00362	CcSEcCtD
Phenazopyridine—Diarrhoea—Rufinamide—epilepsy syndrome	0.000174	0.00359	CcSEcCtD
Phenazopyridine—Nausea—Trimethadione—epilepsy syndrome	0.000174	0.00358	CcSEcCtD
Phenazopyridine—Visual disturbance—Topiramate—epilepsy syndrome	0.000171	0.00352	CcSEcCtD
Phenazopyridine—Pruritus—Lacosamide—epilepsy syndrome	0.000169	0.00348	CcSEcCtD
Phenazopyridine—SCN2A—brain—epilepsy syndrome	0.000167	0.00509	CbGeAlD
Phenazopyridine—Dyspepsia—Midazolam—epilepsy syndrome	0.000165	0.0034	CcSEcCtD
Phenazopyridine—Vomiting—Phenobarbital—epilepsy syndrome	0.000165	0.00339	CcSEcCtD
Phenazopyridine—Pruritus—Clobazam—epilepsy syndrome	0.000164	0.00338	CcSEcCtD
Phenazopyridine—Diarrhoea—Lacosamide—epilepsy syndrome	0.000164	0.00337	CcSEcCtD
Phenazopyridine—Rash—Phenobarbital—epilepsy syndrome	0.000164	0.00337	CcSEcCtD
Phenazopyridine—Dermatitis—Phenobarbital—epilepsy syndrome	0.000163	0.00336	CcSEcCtD
Phenazopyridine—Dyspepsia—Levetiracetam—epilepsy syndrome	0.000163	0.00336	CcSEcCtD
Phenazopyridine—Headache—Phenobarbital—epilepsy syndrome	0.000163	0.00334	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.000162	0.00334	CcSEcCtD
Phenazopyridine—Vomiting—Rufinamide—epilepsy syndrome	0.000162	0.00333	CcSEcCtD
Phenazopyridine—SCN10A—brain—epilepsy syndrome	0.000161	0.00491	CbGeAlD
Phenazopyridine—Rash—Rufinamide—epilepsy syndrome	0.000161	0.0033	CcSEcCtD
Phenazopyridine—Dermatitis—Rufinamide—epilepsy syndrome	0.00016	0.0033	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.00016	0.0033	CcSEcCtD
Phenazopyridine—Headache—Rufinamide—epilepsy syndrome	0.00016	0.00328	CcSEcCtD
Phenazopyridine—Diarrhoea—Clobazam—epilepsy syndrome	0.000159	0.00327	CcSEcCtD
Phenazopyridine—Jaundice—Pregabalin—epilepsy syndrome	0.000158	0.00325	CcSEcCtD
Phenazopyridine—Dyspepsia—Fosphenytoin—epilepsy syndrome	0.000158	0.00324	CcSEcCtD
Phenazopyridine—Visual impairment—Valproic Acid—epilepsy syndrome	0.000155	0.00319	CcSEcCtD
Phenazopyridine—Nausea—Phenobarbital—epilepsy syndrome	0.000154	0.00317	CcSEcCtD
Phenazopyridine—Dyspepsia—Vigabatrin—epilepsy syndrome	0.000154	0.00316	CcSEcCtD
Phenazopyridine—Vomiting—Lacosamide—epilepsy syndrome	0.000152	0.00313	CcSEcCtD
Phenazopyridine—Dyspepsia—Diazepam—epilepsy syndrome	0.000151	0.00311	CcSEcCtD
Phenazopyridine—Nausea—Rufinamide—epilepsy syndrome	0.000151	0.00311	CcSEcCtD
Phenazopyridine—Rash—Lacosamide—epilepsy syndrome	0.000151	0.0031	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000151	0.0031	CcSEcCtD
Phenazopyridine—Dermatitis—Lacosamide—epilepsy syndrome	0.000151	0.0031	CcSEcCtD
Phenazopyridine—Headache—Lacosamide—epilepsy syndrome	0.00015	0.00308	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000148	0.00305	CcSEcCtD
Phenazopyridine—Vomiting—Clobazam—epilepsy syndrome	0.000148	0.00304	CcSEcCtD
Phenazopyridine—SCN3A—brain—epilepsy syndrome	0.000147	0.00447	CbGeAlD
Phenazopyridine—Dyspepsia—Felbamate—epilepsy syndrome	0.000146	0.00301	CcSEcCtD
Phenazopyridine—Rash—Clobazam—epilepsy syndrome	0.000146	0.00301	CcSEcCtD
Phenazopyridine—SCN5A—brain—epilepsy syndrome	0.000146	0.00446	CbGeAlD
Phenazopyridine—Dermatitis—Clobazam—epilepsy syndrome	0.000146	0.00301	CcSEcCtD
Phenazopyridine—Hepatitis—Pregabalin—epilepsy syndrome	0.000145	0.00299	CcSEcCtD
Phenazopyridine—Headache—Clobazam—epilepsy syndrome	0.000145	0.00299	CcSEcCtD
Phenazopyridine—Jaundice—Gabapentin—epilepsy syndrome	0.000145	0.00298	CcSEcCtD
Phenazopyridine—Dyspepsia—Zonisamide—epilepsy syndrome	0.000143	0.00295	CcSEcCtD
Phenazopyridine—Nausea—Lacosamide—epilepsy syndrome	0.000142	0.00292	CcSEcCtD
Phenazopyridine—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000142	0.00291	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000141	0.00289	CcSEcCtD
Phenazopyridine—Visual impairment—Pregabalin—epilepsy syndrome	0.00014	0.00288	CcSEcCtD
Phenazopyridine—Hypersensitivity—Midazolam—epilepsy syndrome	0.000138	0.00285	CcSEcCtD
Phenazopyridine—Dyspepsia—Clonazepam—epilepsy syndrome	0.000138	0.00284	CcSEcCtD
Phenazopyridine—Nausea—Clobazam—epilepsy syndrome	0.000138	0.00284	CcSEcCtD
Phenazopyridine—Dyspepsia—Phenytoin—epilepsy syndrome	0.000137	0.00282	CcSEcCtD
Phenazopyridine—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000137	0.00281	CcSEcCtD
Phenazopyridine—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000137	0.00281	CcSEcCtD
Phenazopyridine—Pruritus—Propofol—epilepsy syndrome	0.000136	0.0028	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000136	0.00279	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000135	0.00277	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000134	0.00276	CcSEcCtD
Phenazopyridine—Hepatitis—Gabapentin—epilepsy syndrome	0.000133	0.00274	CcSEcCtD
Phenazopyridine—Pruritus—Midazolam—epilepsy syndrome	0.000133	0.00274	CcSEcCtD
Phenazopyridine—Vomiting—Acetazolamide—epilepsy syndrome	0.000132	0.00271	CcSEcCtD
Phenazopyridine—Diarrhoea—Propofol—epilepsy syndrome	0.000131	0.0027	CcSEcCtD
Phenazopyridine—Pruritus—Levetiracetam—epilepsy syndrome	0.000131	0.0027	CcSEcCtD
Phenazopyridine—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000131	0.0027	CcSEcCtD
Phenazopyridine—Headache—Acetazolamide—epilepsy syndrome	0.00013	0.00267	CcSEcCtD
Phenazopyridine—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000129	0.00265	CcSEcCtD
Phenazopyridine—Visual impairment—Gabapentin—epilepsy syndrome	0.000129	0.00264	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000128	0.00264	CcSEcCtD
Phenazopyridine—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000127	0.00261	CcSEcCtD
Phenazopyridine—Pruritus—Fosphenytoin—epilepsy syndrome	0.000127	0.00261	CcSEcCtD
Phenazopyridine—Hypersensitivity—Diazepam—epilepsy syndrome	0.000127	0.00261	CcSEcCtD
Phenazopyridine—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000127	0.00261	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000124	0.00256	CcSEcCtD
Phenazopyridine—Pruritus—Vigabatrin—epilepsy syndrome	0.000124	0.00254	CcSEcCtD
Phenazopyridine—Nausea—Acetazolamide—epilepsy syndrome	0.000123	0.00253	CcSEcCtD
Phenazopyridine—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000123	0.00252	CcSEcCtD
Phenazopyridine—Vomiting—Propofol—epilepsy syndrome	0.000122	0.00251	CcSEcCtD
Phenazopyridine—Pruritus—Diazepam—epilepsy syndrome	0.000122	0.0025	CcSEcCtD
Phenazopyridine—Rash—Propofol—epilepsy syndrome	0.000121	0.00249	CcSEcCtD
Phenazopyridine—Dermatitis—Propofol—epilepsy syndrome	0.000121	0.00249	CcSEcCtD
Phenazopyridine—Headache—Propofol—epilepsy syndrome	0.00012	0.00248	CcSEcCtD
Phenazopyridine—Hypersensitivity—Zonisamide—epilepsy syndrome	0.00012	0.00247	CcSEcCtD
Phenazopyridine—Vomiting—Midazolam—epilepsy syndrome	0.00012	0.00246	CcSEcCtD
Phenazopyridine—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000119	0.00246	CcSEcCtD
Phenazopyridine—Rash—Midazolam—epilepsy syndrome	0.000119	0.00244	CcSEcCtD
Phenazopyridine—Dermatitis—Midazolam—epilepsy syndrome	0.000118	0.00244	CcSEcCtD
Phenazopyridine—Vomiting—Levetiracetam—epilepsy syndrome	0.000118	0.00243	CcSEcCtD
Phenazopyridine—Headache—Midazolam—epilepsy syndrome	0.000118	0.00242	CcSEcCtD
Phenazopyridine—Pruritus—Felbamate—epilepsy syndrome	0.000118	0.00242	CcSEcCtD
Phenazopyridine—Diarrhoea—Diazepam—epilepsy syndrome	0.000118	0.00242	CcSEcCtD
Phenazopyridine—Rash—Levetiracetam—epilepsy syndrome	0.000117	0.00241	CcSEcCtD
Phenazopyridine—Dermatitis—Levetiracetam—epilepsy syndrome	0.000117	0.00241	CcSEcCtD
Phenazopyridine—Headache—Levetiracetam—epilepsy syndrome	0.000116	0.00239	CcSEcCtD
Phenazopyridine—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000116	0.00238	CcSEcCtD
Phenazopyridine—Pruritus—Zonisamide—epilepsy syndrome	0.000115	0.00237	CcSEcCtD
Phenazopyridine—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000115	0.00236	CcSEcCtD
Phenazopyridine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000114	0.00235	CcSEcCtD
Phenazopyridine—Nausea—Propofol—epilepsy syndrome	0.000114	0.00235	CcSEcCtD
Phenazopyridine—Vomiting—Fosphenytoin—epilepsy syndrome	0.000114	0.00234	CcSEcCtD
Phenazopyridine—Diarrhoea—Felbamate—epilepsy syndrome	0.000114	0.00234	CcSEcCtD
Phenazopyridine—Rash—Fosphenytoin—epilepsy syndrome	0.000113	0.00232	CcSEcCtD
Phenazopyridine—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000113	0.00232	CcSEcCtD
Phenazopyridine—Headache—Fosphenytoin—epilepsy syndrome	0.000112	0.00231	CcSEcCtD
Phenazopyridine—Hepatitis—Topiramate—epilepsy syndrome	0.000112	0.00231	CcSEcCtD
Phenazopyridine—Nausea—Midazolam—epilepsy syndrome	0.000112	0.0023	CcSEcCtD
Phenazopyridine—Diarrhoea—Zonisamide—epilepsy syndrome	0.000111	0.00229	CcSEcCtD
Phenazopyridine—Pruritus—Clonazepam—epilepsy syndrome	0.000111	0.00229	CcSEcCtD
Phenazopyridine—Vomiting—Vigabatrin—epilepsy syndrome	0.000111	0.00228	CcSEcCtD
Phenazopyridine—Pruritus—Phenytoin—epilepsy syndrome	0.00011	0.00227	CcSEcCtD
Phenazopyridine—Nausea—Levetiracetam—epilepsy syndrome	0.00011	0.00227	CcSEcCtD
Phenazopyridine—Rash—Vigabatrin—epilepsy syndrome	0.00011	0.00227	CcSEcCtD
Phenazopyridine—Dermatitis—Vigabatrin—epilepsy syndrome	0.00011	0.00226	CcSEcCtD
Phenazopyridine—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00011	0.00226	CcSEcCtD
Phenazopyridine—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.00011	0.00226	CcSEcCtD
Phenazopyridine—Headache—Vigabatrin—epilepsy syndrome	0.000109	0.00225	CcSEcCtD
Phenazopyridine—Vomiting—Diazepam—epilepsy syndrome	0.000109	0.00225	CcSEcCtD
Phenazopyridine—Rash—Diazepam—epilepsy syndrome	0.000108	0.00223	CcSEcCtD
Phenazopyridine—Dermatitis—Diazepam—epilepsy syndrome	0.000108	0.00223	CcSEcCtD
Phenazopyridine—Visual impairment—Topiramate—epilepsy syndrome	0.000108	0.00222	CcSEcCtD
Phenazopyridine—Headache—Diazepam—epilepsy syndrome	0.000108	0.00222	CcSEcCtD
Phenazopyridine—Diarrhoea—Clonazepam—epilepsy syndrome	0.000107	0.00221	CcSEcCtD
Phenazopyridine—Diarrhoea—Phenytoin—epilepsy syndrome	0.000107	0.0022	CcSEcCtD
Phenazopyridine—Nausea—Fosphenytoin—epilepsy syndrome	0.000106	0.00219	CcSEcCtD
Phenazopyridine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000106	0.00218	CcSEcCtD
Phenazopyridine—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000106	0.00218	CcSEcCtD
Phenazopyridine—Vomiting—Felbamate—epilepsy syndrome	0.000106	0.00218	CcSEcCtD
Phenazopyridine—Pruritus—Carbamazepine—epilepsy syndrome	0.000105	0.00217	CcSEcCtD
Phenazopyridine—Rash—Felbamate—epilepsy syndrome	0.000105	0.00216	CcSEcCtD
Phenazopyridine—Dermatitis—Felbamate—epilepsy syndrome	0.000105	0.00216	CcSEcCtD
Phenazopyridine—Headache—Felbamate—epilepsy syndrome	0.000104	0.00214	CcSEcCtD
Phenazopyridine—Nausea—Vigabatrin—epilepsy syndrome	0.000104	0.00213	CcSEcCtD
Phenazopyridine—Vomiting—Zonisamide—epilepsy syndrome	0.000104	0.00213	CcSEcCtD
Phenazopyridine—Rash—Zonisamide—epilepsy syndrome	0.000103	0.00211	CcSEcCtD
Phenazopyridine—Dermatitis—Zonisamide—epilepsy syndrome	0.000103	0.00211	CcSEcCtD
Phenazopyridine—Nausea—Diazepam—epilepsy syndrome	0.000102	0.0021	CcSEcCtD
Phenazopyridine—Headache—Zonisamide—epilepsy syndrome	0.000102	0.0021	CcSEcCtD
Phenazopyridine—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000102	0.0021	CcSEcCtD
Phenazopyridine—Pruritus—Lamotrigine—epilepsy syndrome	0.000102	0.00209	CcSEcCtD
Phenazopyridine—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000101	0.00207	CcSEcCtD
Phenazopyridine—Vomiting—Clonazepam—epilepsy syndrome	9.98e-05	0.00205	CcSEcCtD
Phenazopyridine—Vomiting—Phenytoin—epilepsy syndrome	9.91e-05	0.00204	CcSEcCtD
Phenazopyridine—Rash—Clonazepam—epilepsy syndrome	9.9e-05	0.00204	CcSEcCtD
Phenazopyridine—Dermatitis—Clonazepam—epilepsy syndrome	9.89e-05	0.00203	CcSEcCtD
Phenazopyridine—Nausea—Felbamate—epilepsy syndrome	9.88e-05	0.00203	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.87e-05	0.00203	CcSEcCtD
Phenazopyridine—Vomiting—Oxcarbazepine—epilepsy syndrome	9.86e-05	0.00203	CcSEcCtD
Phenazopyridine—Diarrhoea—Lamotrigine—epilepsy syndrome	9.84e-05	0.00203	CcSEcCtD
Phenazopyridine—Headache—Clonazepam—epilepsy syndrome	9.83e-05	0.00202	CcSEcCtD
Phenazopyridine—Rash—Phenytoin—epilepsy syndrome	9.83e-05	0.00202	CcSEcCtD
Phenazopyridine—Dermatitis—Phenytoin—epilepsy syndrome	9.82e-05	0.00202	CcSEcCtD
Phenazopyridine—Rash—Oxcarbazepine—epilepsy syndrome	9.78e-05	0.00201	CcSEcCtD
Phenazopyridine—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.77e-05	0.00201	CcSEcCtD
Phenazopyridine—Headache—Phenytoin—epilepsy syndrome	9.77e-05	0.00201	CcSEcCtD
Phenazopyridine—Headache—Oxcarbazepine—epilepsy syndrome	9.72e-05	0.002	CcSEcCtD
Phenazopyridine—Nausea—Zonisamide—epilepsy syndrome	9.67e-05	0.00199	CcSEcCtD
Phenazopyridine—Vomiting—Carbamazepine—epilepsy syndrome	9.46e-05	0.00195	CcSEcCtD
Phenazopyridine—Rash—Carbamazepine—epilepsy syndrome	9.38e-05	0.00193	CcSEcCtD
Phenazopyridine—Dermatitis—Carbamazepine—epilepsy syndrome	9.38e-05	0.00193	CcSEcCtD
Phenazopyridine—Nausea—Clonazepam—epilepsy syndrome	9.32e-05	0.00192	CcSEcCtD
Phenazopyridine—Headache—Carbamazepine—epilepsy syndrome	9.32e-05	0.00192	CcSEcCtD
Phenazopyridine—Nausea—Phenytoin—epilepsy syndrome	9.26e-05	0.00191	CcSEcCtD
Phenazopyridine—Nausea—Oxcarbazepine—epilepsy syndrome	9.21e-05	0.0019	CcSEcCtD
Phenazopyridine—Vomiting—Lamotrigine—epilepsy syndrome	9.15e-05	0.00188	CcSEcCtD
Phenazopyridine—Rash—Lamotrigine—epilepsy syndrome	9.07e-05	0.00187	CcSEcCtD
Phenazopyridine—Dermatitis—Lamotrigine—epilepsy syndrome	9.06e-05	0.00186	CcSEcCtD
Phenazopyridine—Headache—Lamotrigine—epilepsy syndrome	9.01e-05	0.00185	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.92e-05	0.00184	CcSEcCtD
Phenazopyridine—Nausea—Carbamazepine—epilepsy syndrome	8.84e-05	0.00182	CcSEcCtD
Phenazopyridine—Nausea—Lamotrigine—epilepsy syndrome	8.54e-05	0.00176	CcSEcCtD
Phenazopyridine—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.42e-05	0.00173	CcSEcCtD
Phenazopyridine—Dyspepsia—Gabapentin—epilepsy syndrome	8.34e-05	0.00172	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	8.18e-05	0.00168	CcSEcCtD
Phenazopyridine—Pruritus—Valproic Acid—epilepsy syndrome	8.09e-05	0.00166	CcSEcCtD
Phenazopyridine—Diarrhoea—Valproic Acid—epilepsy syndrome	7.82e-05	0.00161	CcSEcCtD
Phenazopyridine—Hypersensitivity—Pregabalin—epilepsy syndrome	7.61e-05	0.00157	CcSEcCtD
Phenazopyridine—Pruritus—Pregabalin—epilepsy syndrome	7.31e-05	0.0015	CcSEcCtD
Phenazopyridine—Vomiting—Valproic Acid—epilepsy syndrome	7.27e-05	0.0015	CcSEcCtD
Phenazopyridine—Rash—Valproic Acid—epilepsy syndrome	7.21e-05	0.00148	CcSEcCtD
Phenazopyridine—Dermatitis—Valproic Acid—epilepsy syndrome	7.2e-05	0.00148	CcSEcCtD
Phenazopyridine—Headache—Valproic Acid—epilepsy syndrome	7.16e-05	0.00147	CcSEcCtD
Phenazopyridine—Diarrhoea—Pregabalin—epilepsy syndrome	7.07e-05	0.00145	CcSEcCtD
Phenazopyridine—Dyspepsia—Topiramate—epilepsy syndrome	7.02e-05	0.00144	CcSEcCtD
Phenazopyridine—Hypersensitivity—Gabapentin—epilepsy syndrome	6.98e-05	0.00144	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.88e-05	0.00142	CcSEcCtD
Phenazopyridine—Nausea—Valproic Acid—epilepsy syndrome	6.79e-05	0.0014	CcSEcCtD
Phenazopyridine—Pruritus—Gabapentin—epilepsy syndrome	6.7e-05	0.00138	CcSEcCtD
Phenazopyridine—Vomiting—Pregabalin—epilepsy syndrome	6.57e-05	0.00135	CcSEcCtD
Phenazopyridine—Rash—Pregabalin—epilepsy syndrome	6.52e-05	0.00134	CcSEcCtD
Phenazopyridine—Dermatitis—Pregabalin—epilepsy syndrome	6.51e-05	0.00134	CcSEcCtD
Phenazopyridine—Diarrhoea—Gabapentin—epilepsy syndrome	6.48e-05	0.00133	CcSEcCtD
Phenazopyridine—Headache—Pregabalin—epilepsy syndrome	6.47e-05	0.00133	CcSEcCtD
Phenazopyridine—Nausea—Pregabalin—epilepsy syndrome	6.14e-05	0.00126	CcSEcCtD
Phenazopyridine—Vomiting—Gabapentin—epilepsy syndrome	6.02e-05	0.00124	CcSEcCtD
Phenazopyridine—Rash—Gabapentin—epilepsy syndrome	5.97e-05	0.00123	CcSEcCtD
Phenazopyridine—Dermatitis—Gabapentin—epilepsy syndrome	5.97e-05	0.00123	CcSEcCtD
Phenazopyridine—Headache—Gabapentin—epilepsy syndrome	5.94e-05	0.00122	CcSEcCtD
Phenazopyridine—Hypersensitivity—Topiramate—epilepsy syndrome	5.87e-05	0.00121	CcSEcCtD
Phenazopyridine—Pruritus—Topiramate—epilepsy syndrome	5.64e-05	0.00116	CcSEcCtD
Phenazopyridine—Nausea—Gabapentin—epilepsy syndrome	5.63e-05	0.00116	CcSEcCtD
Phenazopyridine—Diarrhoea—Topiramate—epilepsy syndrome	5.45e-05	0.00112	CcSEcCtD
Phenazopyridine—Vomiting—Topiramate—epilepsy syndrome	5.07e-05	0.00104	CcSEcCtD
Phenazopyridine—Rash—Topiramate—epilepsy syndrome	5.03e-05	0.00103	CcSEcCtD
Phenazopyridine—Dermatitis—Topiramate—epilepsy syndrome	5.02e-05	0.00103	CcSEcCtD
Phenazopyridine—Headache—Topiramate—epilepsy syndrome	4.99e-05	0.00103	CcSEcCtD
Phenazopyridine—Nausea—Topiramate—epilepsy syndrome	4.74e-05	0.000974	CcSEcCtD
Phenazopyridine—SCN8A—Developmental Biology—AKT3—epilepsy syndrome	1.45e-05	0.000186	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—CDC42—epilepsy syndrome	1.45e-05	0.000186	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—GDNF—epilepsy syndrome	1.45e-05	0.000186	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—FYN—epilepsy syndrome	1.45e-05	0.000186	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—MEF2C—epilepsy syndrome	1.44e-05	0.000185	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	1.44e-05	0.000184	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—CDC42—epilepsy syndrome	1.44e-05	0.000184	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—IL6ST—epilepsy syndrome	1.43e-05	0.000183	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—ADAM10—epilepsy syndrome	1.43e-05	0.000183	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—ADAM10—epilepsy syndrome	1.43e-05	0.000183	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—ACTB—epilepsy syndrome	1.43e-05	0.000183	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—ACTB—epilepsy syndrome	1.43e-05	0.000183	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	1.42e-05	0.000182	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—ADAM10—epilepsy syndrome	1.42e-05	0.000182	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	1.42e-05	0.000181	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SPTAN1—epilepsy syndrome	1.4e-05	0.00018	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—ITGA2—epilepsy syndrome	1.4e-05	0.000179	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—ITGA2—epilepsy syndrome	1.4e-05	0.000179	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—CDC42—epilepsy syndrome	1.38e-05	0.000177	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—CDC42—epilepsy syndrome	1.38e-05	0.000177	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—ACTB—epilepsy syndrome	1.38e-05	0.000176	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—ACTB—epilepsy syndrome	1.38e-05	0.000176	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—KDR—epilepsy syndrome	1.36e-05	0.000175	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—ACTB—epilepsy syndrome	1.35e-05	0.000173	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	1.35e-05	0.000173	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—ITGA2—epilepsy syndrome	1.35e-05	0.000173	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—ITGA2—epilepsy syndrome	1.35e-05	0.000173	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—FYN—epilepsy syndrome	1.34e-05	0.000171	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—CDC42—epilepsy syndrome	1.33e-05	0.000171	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—CDC42—epilepsy syndrome	1.33e-05	0.000171	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—ITGA2—epilepsy syndrome	1.33e-05	0.00017	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—HES1—epilepsy syndrome	1.33e-05	0.00017	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—CDC42—epilepsy syndrome	1.33e-05	0.00017	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—IL6ST—epilepsy syndrome	1.31e-05	0.000167	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—DLG4—epilepsy syndrome	1.3e-05	0.000167	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—FYN—epilepsy syndrome	1.29e-05	0.000165	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MEF2C—epilepsy syndrome	1.28e-05	0.000164	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—FYN—epilepsy syndrome	1.28e-05	0.000164	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—GRIN2B—epilepsy syndrome	1.27e-05	0.000163	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—DLG4—epilepsy syndrome	1.25e-05	0.00016	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—FYN—epilepsy syndrome	1.23e-05	0.000158	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—FYN—epilepsy syndrome	1.23e-05	0.000158	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—GRIN2B—epilepsy syndrome	1.22e-05	0.000156	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—HES1—epilepsy syndrome	1.21e-05	0.000156	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—DLG4—epilepsy syndrome	1.2e-05	0.000153	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—DLG4—epilepsy syndrome	1.2e-05	0.000153	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—KDR—epilepsy syndrome	1.19e-05	0.000153	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—FYN—epilepsy syndrome	1.19e-05	0.000152	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—FYN—epilepsy syndrome	1.19e-05	0.000152	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—FYN—epilepsy syndrome	1.18e-05	0.000151	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—AKT3—epilepsy syndrome	1.18e-05	0.000151	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MEF2C—epilepsy syndrome	1.17e-05	0.00015	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—GRIN2B—epilepsy syndrome	1.17e-05	0.00015	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—GRIN2B—epilepsy syndrome	1.17e-05	0.00015	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TCF4—epilepsy syndrome	1.16e-05	0.000148	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—DLG4—epilepsy syndrome	1.16e-05	0.000148	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—DLG4—epilepsy syndrome	1.16e-05	0.000148	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—ADAM10—epilepsy syndrome	1.15e-05	0.000147	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—IL6ST—epilepsy syndrome	1.14e-05	0.000147	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—DLG4—epilepsy syndrome	1.14e-05	0.000146	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—GRIN2B—epilepsy syndrome	1.13e-05	0.000145	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—GRIN2B—epilepsy syndrome	1.13e-05	0.000145	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—AKT3—epilepsy syndrome	1.12e-05	0.000144	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—GRIN2B—epilepsy syndrome	1.11e-05	0.000142	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—KDR—epilepsy syndrome	1.1e-05	0.000141	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—ADAM10—epilepsy syndrome	1.1e-05	0.000141	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PRNP—epilepsy syndrome	1.1e-05	0.000141	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—AKT3—epilepsy syndrome	1.08e-05	0.000138	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—AKT3—epilepsy syndrome	1.08e-05	0.000138	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—CDC42—epilepsy syndrome	1.07e-05	0.000137	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—KDR—epilepsy syndrome	1.06e-05	0.000136	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—IL6ST—epilepsy syndrome	1.06e-05	0.000135	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—ADAM10—epilepsy syndrome	1.06e-05	0.000135	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—ADAM10—epilepsy syndrome	1.06e-05	0.000135	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—KDR—epilepsy syndrome	1.06e-05	0.000135	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—AKT3—epilepsy syndrome	1.04e-05	0.000133	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—AKT3—epilepsy syndrome	1.04e-05	0.000133	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CDH2—epilepsy syndrome	1.03e-05	0.000132	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—SRC—epilepsy syndrome	1.03e-05	0.000132	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—MMP9—epilepsy syndrome	1.03e-05	0.000131	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—CDC42—epilepsy syndrome	1.03e-05	0.000131	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—IL6ST—epilepsy syndrome	1.02e-05	0.000131	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—ADAM10—epilepsy syndrome	1.02e-05	0.00013	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—ADAM10—epilepsy syndrome	1.02e-05	0.00013	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—KDR—epilepsy syndrome	1.01e-05	0.00013	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—KDR—epilepsy syndrome	1.01e-05	0.00013	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—IL6ST—epilepsy syndrome	1.01e-05	0.00013	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—ADAM10—epilepsy syndrome	1e-05	0.000128	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CDC42—epilepsy syndrome	9.86e-06	0.000126	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CDC42—epilepsy syndrome	9.86e-06	0.000126	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—HES1—epilepsy syndrome	9.82e-06	0.000126	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—KDR—epilepsy syndrome	9.78e-06	0.000125	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—KDR—epilepsy syndrome	9.78e-06	0.000125	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—KDR—epilepsy syndrome	9.74e-06	0.000125	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—IL6ST—epilepsy syndrome	9.72e-06	0.000124	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—IL6ST—epilepsy syndrome	9.72e-06	0.000124	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ACTB—epilepsy syndrome	9.67e-06	0.000124	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—FYN—epilepsy syndrome	9.55e-06	0.000122	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CDC42—epilepsy syndrome	9.51e-06	0.000122	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CDC42—epilepsy syndrome	9.51e-06	0.000122	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MEF2C—epilepsy syndrome	9.5e-06	0.000122	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ITGA2—epilepsy syndrome	9.5e-06	0.000122	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—SRC—epilepsy syndrome	9.47e-06	0.000121	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—HES1—epilepsy syndrome	9.4e-06	0.00012	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—IL6ST—epilepsy syndrome	9.37e-06	0.00012	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—IL6ST—epilepsy syndrome	9.37e-06	0.00012	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—CDC42—epilepsy syndrome	9.37e-06	0.00012	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—IL6ST—epilepsy syndrome	9.33e-06	0.000119	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—FGF2—epilepsy syndrome	9.26e-06	0.000119	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—VEGFA—epilepsy syndrome	9.22e-06	0.000118	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—MMP9—epilepsy syndrome	9.15e-06	0.000117	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—FYN—epilepsy syndrome	9.14e-06	0.000117	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MEF2C—epilepsy syndrome	9.09e-06	0.000116	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—HES1—epilepsy syndrome	9.03e-06	0.000116	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—HES1—epilepsy syndrome	9.03e-06	0.000116	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—FYN—epilepsy syndrome	8.78e-06	0.000112	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—FYN—epilepsy syndrome	8.78e-06	0.000112	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MEF2C—epilepsy syndrome	8.73e-06	0.000112	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MEF2C—epilepsy syndrome	8.73e-06	0.000112	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—HES1—epilepsy syndrome	8.71e-06	0.000111	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—HES1—epilepsy syndrome	8.71e-06	0.000111	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—RELA—epilepsy syndrome	8.6e-06	0.00011	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—FYN—epilepsy syndrome	8.47e-06	0.000108	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—FYN—epilepsy syndrome	8.47e-06	0.000108	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—SRC—epilepsy syndrome	8.44e-06	0.000108	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MEF2C—epilepsy syndrome	8.42e-06	0.000108	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MEF2C—epilepsy syndrome	8.42e-06	0.000108	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—MMP9—epilepsy syndrome	8.37e-06	0.000107	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—FYN—epilepsy syndrome	8.34e-06	0.000107	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—FGF2—epilepsy syndrome	8.25e-06	0.000106	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—VEGFA—epilepsy syndrome	8.22e-06	0.000105	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—DLG4—epilepsy syndrome	8.12e-06	0.000104	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	8.03e-06	0.000103	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	8.01e-06	0.000103	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—GRIN2B—epilepsy syndrome	7.94e-06	0.000102	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—KDR—epilepsy syndrome	7.87e-06	0.000101	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	7.78e-06	9.96e-05	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—SRC—epilepsy syndrome	7.72e-06	9.88e-05	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—RELA—epilepsy syndrome	7.66e-06	9.81e-05	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—FGF2—epilepsy syndrome	7.55e-06	9.66e-05	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—IL6ST—epilepsy syndrome	7.55e-06	9.66e-05	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—KDR—epilepsy syndrome	7.53e-06	9.64e-05	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—VEGFA—epilepsy syndrome	7.52e-06	9.62e-05	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—MMP9—epilepsy syndrome	7.33e-06	9.38e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—AKT3—epilepsy syndrome	7.33e-06	9.38e-05	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—KDR—epilepsy syndrome	7.24e-06	9.26e-05	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—KDR—epilepsy syndrome	7.24e-06	9.26e-05	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—IL6ST—epilepsy syndrome	7.22e-06	9.24e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ADAM10—epilepsy syndrome	7.16e-06	9.16e-05	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—RELA—epilepsy syndrome	7.01e-06	8.97e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—KDR—epilepsy syndrome	6.98e-06	8.93e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—KDR—epilepsy syndrome	6.98e-06	8.93e-05	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—IL6ST—epilepsy syndrome	6.94e-06	8.88e-05	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—IL6ST—epilepsy syndrome	6.94e-06	8.88e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—KDR—epilepsy syndrome	6.87e-06	8.8e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	6.8e-06	8.7e-05	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—MMP9—epilepsy syndrome	6.77e-06	8.67e-05	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—SRC—epilepsy syndrome	6.76e-06	8.65e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—IL6ST—epilepsy syndrome	6.69e-06	8.56e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—IL6ST—epilepsy syndrome	6.69e-06	8.56e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CDC42—epilepsy syndrome	6.69e-06	8.56e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—IL6ST—epilepsy syndrome	6.59e-06	8.44e-05	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—VEGFA—epilepsy syndrome	6.58e-06	8.42e-05	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MMP9—epilepsy syndrome	6.53e-06	8.36e-05	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—MMP9—epilepsy syndrome	6.47e-06	8.29e-05	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—SRC—epilepsy syndrome	6.24e-06	7.99e-05	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MMP9—epilepsy syndrome	6.22e-06	7.96e-05	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MMP9—epilepsy syndrome	6.22e-06	7.96e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HES1—epilepsy syndrome	6.12e-06	7.84e-05	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—FGF2—epilepsy syndrome	6.1e-06	7.82e-05	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—VEGFA—epilepsy syndrome	6.08e-06	7.78e-05	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—SRC—epilepsy syndrome	6.02e-06	7.71e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—MMP9—epilepsy syndrome	6e-06	7.68e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MMP9—epilepsy syndrome	6e-06	7.68e-05	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MMP9—epilepsy syndrome	5.97e-06	7.65e-05	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—SRC—epilepsy syndrome	5.97e-06	7.64e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—FYN—epilepsy syndrome	5.95e-06	7.62e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MEF2C—epilepsy syndrome	5.92e-06	7.58e-05	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—VEGFA—epilepsy syndrome	5.86e-06	7.51e-05	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—FGF2—epilepsy syndrome	5.84e-06	7.48e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	5.82e-06	7.46e-05	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—VEGFA—epilepsy syndrome	5.81e-06	7.44e-05	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—SRC—epilepsy syndrome	5.74e-06	7.34e-05	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—SRC—epilepsy syndrome	5.74e-06	7.34e-05	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—RELA—epilepsy syndrome	5.67e-06	7.26e-05	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TNF—epilepsy syndrome	5.64e-06	7.22e-05	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—FGF2—epilepsy syndrome	5.61e-06	7.18e-05	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—FGF2—epilepsy syndrome	5.61e-06	7.18e-05	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—VEGFA—epilepsy syndrome	5.59e-06	7.15e-05	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—VEGFA—epilepsy syndrome	5.59e-06	7.15e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—SRC—epilepsy syndrome	5.53e-06	7.08e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—SRC—epilepsy syndrome	5.53e-06	7.08e-05	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—SRC—epilepsy syndrome	5.51e-06	7.05e-05	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—RELA—epilepsy syndrome	5.42e-06	6.94e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—FGF2—epilepsy syndrome	5.41e-06	6.93e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—FGF2—epilepsy syndrome	5.41e-06	6.93e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—VEGFA—epilepsy syndrome	5.39e-06	6.9e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—VEGFA—epilepsy syndrome	5.39e-06	6.9e-05	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—VEGFA—epilepsy syndrome	5.36e-06	6.87e-05	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—RELA—epilepsy syndrome	5.21e-06	6.67e-05	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—RELA—epilepsy syndrome	5.21e-06	6.67e-05	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TNF—epilepsy syndrome	5.03e-06	6.43e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—RELA—epilepsy syndrome	5.02e-06	6.43e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—RELA—epilepsy syndrome	5.02e-06	6.43e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—KDR—epilepsy syndrome	4.9e-06	6.28e-05	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MMP9—epilepsy syndrome	4.83e-06	6.18e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—IL6ST—epilepsy syndrome	4.7e-06	6.02e-05	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MMP9—epilepsy syndrome	4.62e-06	5.92e-05	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TNF—epilepsy syndrome	4.6e-06	5.89e-05	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—SRC—epilepsy syndrome	4.45e-06	5.7e-05	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MMP9—epilepsy syndrome	4.44e-06	5.68e-05	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MMP9—epilepsy syndrome	4.44e-06	5.68e-05	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—VEGFA—epilepsy syndrome	4.34e-06	5.55e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MMP9—epilepsy syndrome	4.28e-06	5.48e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MMP9—epilepsy syndrome	4.28e-06	5.48e-05	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—SRC—epilepsy syndrome	4.26e-06	5.45e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MMP9—epilepsy syndrome	4.22e-06	5.4e-05	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—AKT1—epilepsy syndrome	4.2e-06	5.37e-05	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—VEGFA—epilepsy syndrome	4.15e-06	5.31e-05	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—SRC—epilepsy syndrome	4.09e-06	5.24e-05	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—SRC—epilepsy syndrome	4.09e-06	5.24e-05	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—VEGFA—epilepsy syndrome	3.99e-06	5.1e-05	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—VEGFA—epilepsy syndrome	3.99e-06	5.1e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—SRC—epilepsy syndrome	3.95e-06	5.05e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—SRC—epilepsy syndrome	3.95e-06	5.05e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—SRC—epilepsy syndrome	3.89e-06	4.98e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—VEGFA—epilepsy syndrome	3.84e-06	4.92e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—VEGFA—epilepsy syndrome	3.84e-06	4.92e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—FGF2—epilepsy syndrome	3.8e-06	4.87e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—VEGFA—epilepsy syndrome	3.79e-06	4.85e-05	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—AKT1—epilepsy syndrome	3.74e-06	4.79e-05	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TNF—epilepsy syndrome	3.72e-06	4.76e-05	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TNF—epilepsy syndrome	3.56e-06	4.55e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—RELA—epilepsy syndrome	3.53e-06	4.52e-05	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—AKT1—epilepsy syndrome	3.42e-06	4.38e-05	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TNF—epilepsy syndrome	3.42e-06	4.37e-05	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TNF—epilepsy syndrome	3.42e-06	4.37e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TNF—epilepsy syndrome	3.29e-06	4.22e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TNF—epilepsy syndrome	3.29e-06	4.22e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MMP9—epilepsy syndrome	3.01e-06	3.85e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SRC—epilepsy syndrome	2.77e-06	3.55e-05	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—AKT1—epilepsy syndrome	2.77e-06	3.54e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—VEGFA—epilepsy syndrome	2.7e-06	3.46e-05	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—AKT1—epilepsy syndrome	2.65e-06	3.39e-05	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—AKT1—epilepsy syndrome	2.54e-06	3.26e-05	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—AKT1—epilepsy syndrome	2.54e-06	3.26e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—AKT1—epilepsy syndrome	2.45e-06	3.14e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—AKT1—epilepsy syndrome	2.45e-06	3.14e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TNF—epilepsy syndrome	2.32e-06	2.97e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—AKT1—epilepsy syndrome	1.72e-06	2.21e-05	CbGpPWpGaD
